## Abstract Objective: To evaluate the long‐term clinical outcomes of patients undergoing percutaneous coronary intervention for saphenous vein graft (SVG) disease. Specifically, we compared clinical endpoints of patients who received sirolimus‐eluting stents (SES) versus bare‐metal stents (BMS) fo
Long-Term Clinical Benefit of Sirolimus-Eluting Stents Compared to Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease
✍ Scribed by ROBERT M. MINUTELLO; SHERRITA BHAGAN; ATUL SHARMA; ALEXANDER J. SLOTWINER; DMITRIY N. FELDMAN; LINDA J. CUOMO; S. CHIU WONG
- Book ID
- 109216789
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 156 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0896-4327
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Background: Small randomized trials have shown short‐term improved outcome with drug‐eluting stents (DES) over bare metal stent (BMS) in saphenous vein graft (SVG) interventions by reducing in‐stent restenosis and target vessel revascularization (TVR). It is not clear, however, if these
## Abstract Objective: This study compared the efficacy of the sirolimus‐eluting stent (SES), the paclitaxel‐eluting stent (PES), and the bare metal stent (BMS) for long coronary lesions. Background: The outcome of drug‐eluting stent (DES) implantation in long coronary lesions remains unclear. Meth